amgen glp-1 obesity drug market potential 2025 Trends and Global Forecasts Report 2025: A Pharma Giants Bet on Next-Generation
Description
Surging prevalence of type 2 diabetes and growing GLP-1 drug applications are fueling the market growth
Our personalized approach to weight management helps you feel confident and healthier, enhancing your appearance and vitality
Diabetes Control and Complications Trial Research Group
62 Lixisenatide Lixisenatide was developed by Sanofi to treat T2DM
A focus on nutrition is largely missing from the healthcare system
Avalere also utilized the 100% Medicare FFS claims, accessed by Avalere via a research collaboration with Inovalon, Inc
